國立虎尾科技大學 |

Chemotherapy Protocols and Infusion Sequence = Schedule Consideration in Cancer Treatment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Chemotherapy Protocols and Infusion Sequence/ by Iago Dillion Lima Cavalcanti.
其他題名:	Schedule Consideration in Cancer Treatment /
作者:	Lima Cavalcanti, Iago Dillion.
面頁冊數:	X, 325 p. 147 illus., 145 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-3-031-10839-6
ISBN:	9783031108396

Chemotherapy Protocols and Infusion Sequence = Schedule Consideration in Cancer Treatment /
Lima Cavalcanti, Iago Dillion.

Chemotherapy Protocols and Infusion SequenceSchedule Consideration in Cancer Treatment /[electronic resource] :by Iago Dillion Lima Cavalcanti. - 1st ed. 2022. - X, 325 p. 147 illus., 145 illus. in color.online resource.

Polypharmacy in cancer therapy -- Combined therapy for the treatment of cancer -- Importance of the infusion order in the treatment of cancer -- Chemotherapeutic protocols for the treatment of breast cancer -- Chemotherapeutic protocols for the treatment of gastrointestinal tract cancer -- Chemotherapeutic protocols for the treatment of genitourinary cancer -- Chemotherapeutic protocols for the treatment of gynecological cancer -- Chemotherapeutic protocols for the treatment of head and neck cancer -- Chemotherapeutic protocols for the treatment of lung cancer -- Chemotherapeutic protocols for the treatment of neurological cancer.

This book aims to address the infusion sequence of the main protocols used in the treatment of varied solid cancers. Since an inadequate infusion sequence can compromise the patient's treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence. The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy, and discuss the importance of drug combination in cancer treatment. Chapter 2 focuses on the challenges and also the toxicity of combination therapy in cancer, while chapter 3 highlights the parameters that must be evaluated before defining the infusion sequence, such as pharmacodynamic and pharmacokinetic profiles, drugs’ stability when diluted or reconstituted, toxicological profile of each drug, among others. The remaining chapters are divided by type of cancer. The content is focused on solid tumors, dividing the chapters according to breast, gastrointestinal, genitourinary, gynecological, head and neck, lung, and neurological cancers. In each chapter the epidemiological profiles, pathophysiology, therapeutic modalities, and the main chemotherapy protocols are addressed, as well as efficacy studies and data on the infusion sequence of each mentioned protocol. This work will be a valuable resource to physicians, nurses, and pharmacists, and may help to improve health service practices.

ISBN: 9783031108396

Standard No.: 10.1007/978-3-031-10839-6doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Chemotherapy Protocols and Infusion Sequence = Schedule Consideration in Cancer Treatment /
LDR:03472nam a22003975i 4500 001 1084387
003 DE-He213
005 20221018054645.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783031108396 $9 978-3-031-10839-6
024 7 $a 10.1007/978-3-031-10839-6 $2 doi
035 $a 978-3-031-10839-6
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
100 1 $a Lima Cavalcanti, Iago Dillion. $e author. $0 (orcid)0000-0001-6625-8395 $1 https://orcid.org/0000-0001-6625-8395 $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390668
245 1 0 $a Chemotherapy Protocols and Infusion Sequence $h [electronic resource] : $b Schedule Consideration in Cancer Treatment / $c by Iago Dillion Lima Cavalcanti.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a X, 325 p. 147 illus., 145 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Polypharmacy in cancer therapy -- Combined therapy for the treatment of cancer -- Importance of the infusion order in the treatment of cancer -- Chemotherapeutic protocols for the treatment of breast cancer -- Chemotherapeutic protocols for the treatment of gastrointestinal tract cancer -- Chemotherapeutic protocols for the treatment of genitourinary cancer -- Chemotherapeutic protocols for the treatment of gynecological cancer -- Chemotherapeutic protocols for the treatment of head and neck cancer -- Chemotherapeutic protocols for the treatment of lung cancer -- Chemotherapeutic protocols for the treatment of neurological cancer.
520 $a This book aims to address the infusion sequence of the main protocols used in the treatment of varied solid cancers. Since an inadequate infusion sequence can compromise the patient's treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence. The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy, and discuss the importance of drug combination in cancer treatment. Chapter 2 focuses on the challenges and also the toxicity of combination therapy in cancer, while chapter 3 highlights the parameters that must be evaluated before defining the infusion sequence, such as pharmacodynamic and pharmacokinetic profiles, drugs’ stability when diluted or reconstituted, toxicological profile of each drug, among others. The remaining chapters are divided by type of cancer. The content is focused on solid tumors, dividing the chapters according to breast, gastrointestinal, genitourinary, gynecological, head and neck, lung, and neurological cancers. In each chapter the epidemiological profiles, pathophysiology, therapeutic modalities, and the main chemotherapy protocols are addressed, as well as efficacy studies and data on the infusion sequence of each mentioned protocol. This work will be a valuable resource to physicians, nurses, and pharmacists, and may help to improve health service practices.
650 0 $a Pharmacology. $3 583819
650 0 $a Oncology. $3 593951
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783031108389
776 0 8 $i Printed edition: $z 9783031108402
776 0 8 $i Printed edition: $z 9783031108419
856 4 0 $u https://doi.org/10.1007/978-3-031-10839-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)